Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Name: Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
SKU: 2801
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 1 Articles Tags: adverse-events, antipsychotic, cytochrome-p-450, drug-interactions, hepatic, md-deanna-l-kelly, psychotropic, robert-r-conley

Description

Description

Robert R. Conley, MD

DRUG DISPOSITION & PHARMACOKINETICS

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

PB-40-1-07-Conley

Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Description

Robert R. Conley, MD

DRUG DISPOSITION & PHARMACOKINETICS

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

The 2018 Handbook of Psychotropic Drug Interactions

Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF

Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Description

Robert R. Conley, MD

DRUG DISPOSITION & PHARMACOKINETICS

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

Related products

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

The 2018 Handbook of Psychotropic Drug Interactions

Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF